logo
logo

New Equilibrium Bio Raises $10M From Ra Capital For Ai-Powered Quantum Chemistry

Mar 31, 2021•over 4 years ago

Amount Raised

$10 Million

Cambridge

Description

New Equilibrium, the pioneer in rational drug design against intrinsically disordered proteins (IDPs), has closed a $10 million seed from RA Capital Management. New Equilibrium's platform reveals previously-undetectable opportunities for structure-based design by learning biophysics with AI. The seed will scale up New Equilibrium's R&D facility, expand the team, and accelerate programs targeting IDPs while exploring strategic partnerships.

Company Information

Company

New Equilibrium Biosciences:

Location

Cambridge, Maryland, United States

About

Virginia Burger, Ph.D. and Peter Tompa, Ph.D. founded New Equilibrium in 2019 to discover new medicines for patients with life-threatening diseases. NEQ's platform marries AI and biophysics to reveal experimentally-invisible conformations of shapeshifting proteins. This first-in-kind technology enables the rational design of drugs targeting the elusive class of intrinsically disordered proteins, including many of the most desirable targets for cancer, neurodegeneration, and other indications. Supported by a world-class Scientific Advisory Board, New Equilibrium has attracted grant and venture funding to build a cross-disciplinary team of experts in AI, biophysics, and quantum chemistry. To learn more, please visit www.newequilibriumbio.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech